569253-U

Discovery^® HS C18 (3 µm) HPLC Columns

L × I.D. 5 cm × 2.1 mm, HPLC Column

• Sinônimo(s): Discovery RP18 HPLC Column
• Código UNSPSC: 41115700
• eCl@ss: 32110501
• NACRES: SB.52

Propriedades

• product name: Coluna de HPLC C18 Discovery^® HS, 3 μm particle size, L × I.D. 5 cm × 2.1 mm
• Materiais: stainless steel column
• Agency: suitable for USP L1
• linha de produto: Discovery^®
• Características: endcapped
• fabricante/nome comercial: Discovery^®
• embalagem: 1 ea of
• Extensão da rotulagem: 20% Carbon loading
• Parâmetros: ≤70 °C temp. range; 400 bar pressure (5801 psi)
• técnica(s): HPLC: suitable; LC/MS: suitable
• C × D.I.: 5 cm × 2.1 mm
• área da superfície: 300 m²/g
• cobertura de superfície: 3.2 μmol/m²
• Impurezas: <10 ppm metals
• matriz: silica gel, high purity, spherical particle platform; fully porous particle
• Grupo ativo da matriz: C18 (octadecyl) phase
• tamanho de partícula: 3 μm
• tamanho de poro: 120 Å
• operating pH range: 2-8
• aplicação(ões): food and beverages
• técnica de separação: reversed phase

Descrição

Descrição geral

Discovery^® HS C18 HPLC column (L × I.D. 5 cm × 2.1 mm) is commonly found to be stable under acidic and basic conditions.

Aplicação

• Stereoselective separation of omeprazole and 5-hydroxy-omeprazole using dried plasma spots and a heart-cutting 2D-LC approach for accurate CYP2C19 phenotyping: This research utilizes the Discovery^® HS C18 HPLC column for its superior selectivity and sensitivity in pharmacogenetic studies, providing vital data for personalized medicine approaches in drug metabolism (Abouir et al., 2024).


• A stability indicating RP-HPLC method for determination of the COVID-19 drug molnupiravir applied using nanoformulations in permeability studies: This study highlights the effectiveness of the Discovery^® HS C18 column in the rapid and accurate analysis of molnupiravir, emphasizing its role in supporting fast-paced pharmaceutical research and development (Reçber et al., 2022).


• Sensitive Analysis of Idarubicin in Human Urine and Plasma by Liquid Chromatography with Fluorescence Detection: This application underlines the Discovery^® HS C18 column′s high sensitivity and robustness in clinical diagnostics, crucial for monitoring therapeutic drugs and their metabolites in complex biological matrices (Maliszewska et al., 2020).

Características e benefícios

• Estável, com pouco vazamento, para aplicações de LC-MS
• Escalável do analítico ao preparatório
• Altamente estável para garantir excelente reprodutibilidade entre corridas e entre lotes
• Maior hidrofobicidade para melhor resolução de analitos difíceis

   

Produtos recomendados

Discover LiChropur reagents ideal for HPLC or LC-MS analysis

Informações legais

Discovery is a registered trademark of Merck KGaA, Darmstadt, Germany